Betaseron Related Clinical Trials
Phase IV Study, Betaseron Versus Copaxone for Relapsing Remitting or CIS Forms of MS Using Triple Dose Gad 3 T MRI [Active, not recruiting]
Extension of Prior Study Evaluating Safety and Tolerability of Two Doses of Betaseron® to Treat Relapsing-remitting Multiple Sclerosis [Completed]
BEYOND Follow-up: Betaferon®/Betaseron® Efficacy Yielding Outcomes of a New Dose [Completed]
BENEFIT Study (Betaferon® / Betaseron® in Newly Emerging Multiple Sclerosis for Initial Treatment) and BENEFIT Follow-up Study [Completed]
BEYOND: Betaferon/Betaseron Efficacy Yielding Outcomes of a New Dose in Multiple Sclerosis (MS) Patients [Completed]
Comparison Study of PF530 and Betaferon in Healthy Subjects [Active, not recruiting]
Natalizumab De-escalation With Interferon Beta-1b [Completed]
Natalizumab De-escalation to Interferon-beta-1b in Patients With Relapsing-remitting Multiple Sclerosis [Terminated]
Evaluation of Risk Factors for Early Termination of Injection Treatment With Betaferon in Patients Suffering From Multiple Sclerosis [Completed]
Injection Management With Betaferon: Influence on Adherence, Patients Satisfaction and Health Related Outcomes (BETAPATH) [Completed]
Safety Study in Relapsing-remitting Multiple Sclerosis (RRMS) Patients Receiving Betaferon or Rebif [Completed]
Rehabilitation Study in MS Patients [Terminated]
Physical Disability in Patients Treated With Betaferon [Completed]
BetaPlus Survey - Observational Study to Assess Drug Adherence in Patients With Multiple Sclerosis After Conversion to Betaferon® by Using Elements of the BetaPlus Program [Completed]
Prospective, Multicenter Non Interventional Study to Evaluate Adherence to Betaferon Over a 2 Years Period [Completed]
Portuguese Observational Survey to Assess Drug Adherence in Patients With Multiple Sclerosis After Conversion to Betaferon by Using Elements of the BetaPlus Program - Nurse Support, Auto-injectors [Completed]
Betaseron 16-Year Long-Term Follow-Up (LTF) in Patients With Relapsing-Remitting Multiple Sclerosis [Completed]
Success of Titration, Analgesics, and B.E.T.A Nurse Support on Acceptance Rates in Early Multiple Sclerosis (MS) Treatment With Betaseron [Completed]
QOLBET Quality Of Life in Patients With Early Relapsing-remitting Multiple Sclerosis Treated With BETaferon® in Korea [Withdrawn]
Evaluation of Potential Predictors of Adherence by Investigating a Representative Cohort of Multiple Sclerosis (MS) Patients in Germany Treated With Betaferon [Not yet recruiting]
Combination Therapy of Betaseron-Prograf in Multiple Sclerosis [Active, not recruiting]
Telephone Interview of Patients That Participated in the the Pivotal Betaferon MS Trial. [Completed]
Efficacy, Safety and Tolerability of Atorvastatin 40 mg in Patients With Relapsing-remitting Multiple Sclerosis Treated With Interferon-beta-1b [Completed]
Betaferon/ Betaseron (Interferon Beta-1b) in Patients With Chronic Viral Cardiomyopathy [Completed]
China Betaferon Adherence, Coping and Nurse Support Study [Active, not recruiting]
BAY86-5046 (Betaseron), Non Interventional Studies [Recruiting]
Study Evaluating Betaferons Safety and Tolerability In Pediatric Patients With Multiple Sclerosis [Active, not recruiting]
Open Label Study to Evaluate Effect, Safety and Tolerability of Betaferon Standard Dose of 250µg in Patients of Chinese Origin With Multiple Sclerosis [Completed]
An Efficacy and Safety Comparison Study of Two Marketed Drugs in Patients With Relapsing-remitting MS [Completed]
Depression and Fatigue in MS Patients Treated With Betaferon. [Completed]
Phase III Randomized Double-Blind Placebo Controlled Study To Evaluate the Safety and Efficacy of Betaseron in AIDS and Advanced ARC Patients Receiving a Reduced-Dose AZT Regimen [Completed]
Fingolimod Versus Interferon Beta 1b in Cognitive Symptoms [Active, not recruiting]
RNF and Betaseron� Tolerability Study [Completed]
Atorvastatin 40 mg in Patients With Relapsing-Remitting Multiple Sclerosis Treated With Interferon-Beta-1b [Completed]
Betaferon® Regulatory Post-Marketing Surveillance [Completed]
BEYOND Pilot Study [Completed]
BETAEVAL Global - The New BETACONNECT Auto-injector : Adherence and EVALuation of Multiple Sclerosis Patients Treated With Betaferon [Recruiting]
Betaseron Pregnancy Registry [Completed]
Observational Study to Analyse the Impact of Nurse Support and Disease Related Factors on Long- Term Adherence to Betaferon Treatment [Completed]
Study to Compare Double-dose Betaferon to the Approved Dose, for Patients With Early Secondary Progressive Multiple Sclerosis (SPMS) [Withdrawn]
Colecalciferol as an Add-on Treatment to Subcutaneously-Administered Interferon-beta-1b for Treatment of Multiple Sclerosis (MS) [Completed]
Randomized Study Designed to Look at Disease Progression Using 2 Currently FDA Approved Drugs for the Treatment of RRMS [Terminated]
Investigating the Relationship Between Sleep, Quality of Life,Other Disorders and Therapies in MS Patients on Betaferon [Active, not recruiting]
MOdification of VIsual Outcomes After Optic Neuritis in CIS or MS by Gilenya (MOVING Study) [Recruiting]
Open, Multicentric, Prospective, Quality of Life Study in Multiple Sclerosis Patients [Completed]
Colecalciferol as an Add-on Treatment to Interferon-beta-1b for Treatment of Multiple Sclerosis (MS) [Active, not recruiting]
Costs, Quality of Life and Functional Outcomes in Veterans Treated for Multiple Sclerosis With Beta-Interferon l-B (Betaseron) [Completed]
Comparison of Bone Effects With Copaxone and Interferon in Multiple Sclerosis [Completed]
Clinical 15 Months Study Comparing Monthly Pulse ACTH (Acthar Gel) Therapy With Monthly Methylprednisolone (MP, Solumedrol) for Multiple Sclerosis (MS) Patients Who Are on Regular Beta-interferons (Avonex, Betaseron or Rebif) [Active, not recruiting]
Physical Activity and Fatigue in Early Multiple Sclerosis (MS) [Completed]
Evaluation of a New Therapeutic Strategy in Early and Active Relapsing-Remitting Multiple Sclerosis [Terminated]
Follow-up Study After 11 Years of Patients Who Were Included in the BENEFIT Trial (304747) With a First Demyelinating Event Suggestive of Multiple Sclerosis [Completed]
Patients With Relapse Remitting Multiple Sclerosis (RRMS): Candidates for MS Therapy Change [Completed]
A 6-month, Randomized, Open-label, Patient OutComes, Safety and Tolerability Study of Fingolimod (FTY720) 0.5 mg/Day vs. Comparator in Patients With Relapsing Forms of Multiple Sclerosis [Completed]
Modulation of Plasmacytoid Dendritic Cell Function in Multiple Sclerosis [Completed]
BENEFIT Extension Study [Completed]
Therapy Optimization in Multiple Sclerosis (MS) [Completed]
Effect of Aerobic Exercise on Side Effects of Disease Modifying Therapy With Subcutaneous Interferon-b1b in Patients With Multiple Sclerosis [Recruiting]
The Safety and Effectiveness of Ganciclovir Plus Interferon Beta in Preventing the Return of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS [Completed]
Open Label Phase I Study To Evaluate the Safety of Combination Therapy With AZT and Interferon-Beta in Patients With AIDS Related Kaposi's Sarcoma [Completed]
Stem Cell Therapy for Patients With Multiple Sclerosis Failing Alternate Approved Therapy- A Randomized Study [Recruiting]
Phase 3 Study to Evaluate Efficacy and Safety of NU100 in Patients With Relapsing Remitting Multiple Sclerosis (RRMS) [Active, not recruiting]
Herbal Therapy for Subcutaneous Injection Site Reactions in Multiple Sclerosis [Completed]
Natalizumab as an Efficacy Switch in Participants With Relapsing Multiple Sclerosis (MS) After Failure on Other Therapies [Recruiting]
Safety, Tolerability and Activity Study of Ibudilast in Subjects With Progressive Multiple Sclerosis [Active, not recruiting]
Study Comparing Corpus Callosum Atrophy as a Marker of Later Development of Cognitive Impairment in Patients With Multiple Sclerosis [Not yet recruiting]
A Serologic Study to Correlate Beta-IFN NAb Titers to Beta-IFN Induced Biomarker Response in Patients With Multiple Sclerosis [Completed]
A Multinational, Randomized, Double-blind, Parallel-group, Placebo-controlled Study Assessing the Safety and Tolerability [Withdrawn]
Evaluation of Patient Retention of Fingolimod vs. Currently Approved Disease Modifying Therapy in Patients With Relapsing Remitting Multiple Sclerosis. [Completed]
Optimizing IFN Beta - 1B Dose [Completed]
Validation of Brief Computerized Cognitive Assessment in Multiple Sclerosis (BCCAMS) [Recruiting]
|